Howard Marks
Oaktree Capital Management
Howard Marks Hims Hers Health Inc stake
total: 853
Oaktree Capital Management HIMS trades
- Total transactions:
- 6
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 4
- Held since:
- 2021 Q1
- Held for:
- 15 quarters
- Latest activity:
- 2024 Q4
According to 2026 Q2 report, Howard Marks doesn't hold any Hims Hers Health Inc (HIMS) shares. To date, the estimated cost basis is nearly $13.23 for "buy" trades and estimated average "sell" price is $11.34. Oaktree Capital Management first purchased HIMS in 2021 Q1, initially acquiring about 3.77M shares. Since the initial investment in Hims Hers Health Inc (HIMS), Oaktree Capital Management has made 5 more transactions.
When did Howard Marks sell Hims Hers Health Inc (HIMS)?
Howard Marks sold off the entire Hims Hers Health Inc (HIMS) position in 2024 Q4.
When did Howard Marks buy Hims Hers Health Inc (HIMS)?
Howard Marks first invested in Hims Hers Health Inc (HIMS) in 2021 Q1 at the reported quarter-end price of $13.23 per share.
What's the cost basis of Oaktree Capital Management's HIMS stake?
The estimated cost basis for Hims Hers Health Inc (HIMS) stake is around $13.23 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $13.23
- Weighted AVG sell price:
- $11.34
Howard Marks's historical trades in Hims Hers Health Inc
6 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q4
|
0.00%
|
0
|
$18.42
|
|
-100% (-666,962)
|
-0.2%
|
|
2024 Q1
|
0.17%
|
666,962
|
$15.47
|
$10,317,902
|
-36.67% (-386,252)
|
-0.09%
|
|
2023 Q2
|
0.13%
|
1,053,214
|
$9.40
|
$9,900,211
|
-19.57% (-256,346)
|
-0.03%
|
|
2023 Q1
|
0.15%
|
1,309,560
|
$9.92
|
$12,990,835
|
-59.97% (-1,961,719)
|
-0.21%
|
|
2022 Q1
|
0.19%
|
3,271,279
|
$5.33
|
$17,436,000
|
-13.31% (-502,158)
|
-0.03%
|
|
2021 Q1
|
0.70%
|
3,773,437
|
$13.23
|
$49,923,000
|
new
|
+0.7%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.